Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.

ABSTRACT:

Context

Ductal adenocarcinoma (DAC) is relatively rare, but is nonetheless the second most common subtype of prostate cancer. First described in 1967, opinion is still divided regarding its biology, prognosis, and outcome.

Objectives

To systematically interrogate the literature to clarify the epidemiology, diagnosis, management, progression, and survival statistics of DAC.

Materials and methods

We conducted a literature search of five medical databases from inception to May 04 2020 according to PRISMA criteria using search terms "prostate ductal adenocarcinoma" OR "endometriod adenocarcinoma of prostate" and variations of each.

Results

Some 114 studies were eligible for inclusion, presenting 2 907 170 prostate cancer cases, of which 5911 were DAC. [Correction a

SUBMITTER: Ranasinha N 

PROVIDER: S-EPMC8988764 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature